Related Experiment Video
Updated: Jun 21, 2025
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
11.5K
Frontloading Home Physical Therapy Visits for Patients With Heart Failure: A Multi-center Randomized Controlled Trial
Home Healthcare Now
|July 8, 2024
Summary
Frontloading home physical therapy visits significantly improved function in heart failure patients. This approach demonstrated benefits in gait speed, Timed Up and Go, and chair rise tests over standard care.
Area of Science:
- Cardiovascular Rehabilitation
- Physical Therapy
- Geriatric Medicine
Background:
- Frontloading home care visits are effective in nursing but understudied in physical therapy.
- Heart failure (HF) patients often require home-based rehabilitation post-discharge.
Purpose of the Study:
- To investigate the impact of frontloaded home physical therapy (PT) visits on functional outcomes in patients with heart failure (HF).
Main Methods:
- Prospective, multi-center randomized controlled trial with blinded raters.
- 82 ambulatory HF patients were randomized to a frontloaded group (FLG) or control group (CG) for 4 weeks.
- FLG received 5 PT sessions/week for 2 weeks, then 3 sessions/week for 2 weeks; CG received 2 sessions/week for 4 weeks.
Main Results:
- All participants improved functionally over time (p < .01).
- Significant between-group differences favoring the FLG were found for gait speed (GS) (p = .03), Timed Up and Go (TUG) (p = .02), and 30-second chair rise test (30-CRT) (p = .04).
Conclusions:
- Frontloading home PT visits is a novel and effective strategy for improving function in individuals with HF.
- This approach shows promise for enhancing rehabilitation outcomes in home care settings.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:22Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
195
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
195